HomeTagsManufacturers Association of Nigeria (MAN)

Tag: Manufacturers Association of Nigeria (MAN)

Manufacturers Blame High Interest Rates for N746bn Export Slump

Manufacturers Blame High Interest Rates for N746bn Export Slump   The Manufacturers Association of Nigeria (MAN)  has decried the high interest rates by banks as manufacturing exports crashed from the last peak of N1.04tn in the third quarter of 2024 to N294.43bn in Q1 2025, representing...

MAN Seeks CBN Intervention as Forex Dispute Worsens

MAN Seeks CBN Intervention as Forex Dispute Worsens   The Manufacturers Association of Nigeria (MAN) has decried what it described as “unwholesome treatment” of its members by some commercial banks over unmet foreign exchange forward obligations, calling on the Central Bank of Nigeria to intervene as...

Forex Stability Boosts Manufacturers’ Confidence – MAN

Forex Stability Boosts Manufacturers' Confidence - MAN   Manufacturers are optimistic about the stability of the sector following a challenging period of unsold inventory and economic uncertainty, according to the Chairman of the Manufacturers Association of Nigeria (MAN) Ogun State Chapter, George Onafowokan. It was reported in...

MAN Calls for Electricity Tariff Reduction, Caution on GDP Rebasing

MAN Calls for Electricity Tariff Reduction, Caution on GDP Rebasing   The Manufacturers Association of Nigeria (MAN) has reiterated its determination to push for a reduction in electricity tariffs while cautioning the Federal Government against politicising the planned Gross Domestic Product rebasing process. MAN’s leadership, during its...

Weak Purchasing Power Pushes Unsold Goods to N1.24trn, MAN Reveals

Weak Purchasing Power Pushes Unsold Goods to N1.24trn, MAN Reveals The Manufacturers Association of Nigeria (MAN) has stated its unsold manufactured goods have reached a record N1.24tn, as its unsold inventories increased by 357.57 per cent in the first half of 2024. MAN attributed this sharp...

MAN: Zero VAT Delay Has Reduced Manufacturers’ Revenue By 8%

Pharmaceutical manufacturers have experienced losses of up to eight percent as a result of the Federal Government’s delay in implementing its zero-Value Added Tax policy designed to ease the cost of pharmaceutical raw material imports.